Young Adult Women’s Relationship Status and HPV Risk Perceptions: A Barrier to HPV Vaccination?
Poster May 10, 2018
Rumour P. Piepenbrink; Erika L. Thompson, PhD, MPH, CPH; Cheryl A. Vamos, PhD, MPH; Stacey Griner, MPH, CPH, RDH; Rachel Logan, MPH; Mika Kadono, MPH; Coralia Vazquez-Otero, JD, MPH; Ellen M. Daley, PhD, MPH
Background: Human papillomavirus (HPV) vaccine rates continue to be suboptimal in the United States. Women ages 18-26 years are eligible for catch-up vaccination, yet previous qualitative research indicates women’s relationship status and HPV risk perceptions may be barriers to HPV vaccination. Quantitative studies are needed to expand the generalizability of these findings. The purpose of this study was to assess the association between relationship status and perceived risk for HPV among vaccinated and unvaccinated young adult women.
Methods: Women aged 18-26 years at a Florida university completed an online survey in November 2016-April 2017 (n=305). The survey assessed HPV vaccination status, perceived risk for HPV, and current relationship status. Logistic regression models estimated the odds of perceived high-risk for HPV stratified by vaccination status in SAS 9.4.
Results: Participants reported the following relationship statuses: committed relationship (43%), dating (21%), and single (36%). Most participants received the HPV vaccine (75%) and reported being at low-risk for HPV (78%). Among unvaccinated women, relationship status and HPV risk perception were significantly associated (p=0.01). Specifically, women who were dating were more likely (OR=5.33, 95%CI 1.16-24.5) to perceive a high-risk for HPV compared to women in a committed relationship. No effect was found for relationship status and HPV risk perception among vaccinated women.
Conclusion: Findings corroborate the association between relationship status and HPV risk perceptions among unvaccinated women. Specifically, women in relationships were less likely to perceive themselves at high-risk for HPV, which may not be an accurate assessment given the high prevalence of HPV among young adults. This association is not present for vaccinated women, which may indicate relationship status and risk perceptions are barriers to HPV vaccine uptake. Future research should develop and test health communication messages to address HPV risk misperceptions among young adult women in relationships to promote HPV vaccination.
Characterization of a Type 2 diabetes-associated islet-specific enhancer cluster in STARD10 by genome editing of EndoC-βH1 cellsPoster
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
Treatment Options for Chronic Parvovirus Viremia in Pediatric Heart Transplant Patients in a Tertiary Care CenterPoster
This abstract discusses three cases of pediatric heart transplant patients who suffered from parvovirus (B19) infection. Of these patients, two ( B & C) responded well to standard intravenous Ig therapy. Patient A however, did not respond to standard treatment and was begun on subcutaneous Ig, which effectively diminished his viral load. Thus, subcutaneous Ig infusions might serve as a second line treatment for transplant patients with parvovirus who do not respond well to the standard approach.READ MORE
The Role of K13 in Artemisinin ResistancePoster
Plasmodium falciparum is evolving resistance to Artemisinin Combination Therapy. The gene with the strongest association with resistance is K13. K13 is an ortholog of the well characterized transcriptional regulator Keap1. In this work we transcriptionally characterized a mutant with a transposon inserted in the K13 promoter region which results in dysregulation of K13 at 2 points of the intraerythrocytic cycle of the life-cycle to identify the processes regulated by K13.READ MORE
3rd International Conference on Diagnostic Microbiology and Infectious Diseases
Sep 24 - Sep 25, 2018